Modelling BK Polyomavirus dissemination and cytopathology using polarized human renal tubule epithelial cells.
Journal
PLoS pathogens
ISSN: 1553-7374
Titre abrégé: PLoS Pathog
Pays: United States
ID NLM: 101238921
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
21
07
2023
accepted:
17
08
2023
revised:
08
09
2023
medline:
11
9
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
epublish
Résumé
Most humans have a lifelong imperceptible BK Polyomavirus (BKPyV) infection in epithelial cells lining the reno-urinary tract. In kidney transplant recipients, unrestricted high-level replication of donor-derived BKPyV in the allograft underlies polyomavirus-associated nephropathy, a condition with massive epithelial cell loss and inflammation causing premature allograft failure. There is limited understanding on how BKPyV disseminates throughout the reno-urinary tract and sometimes causes kidney damage. Tubule epithelial cells are tightly connected and have unique apical and basolateral membrane domains with highly specialized functions but all in vitro BKPyV studies have been performed in non-polarized cells. We therefore generated a polarized cell model of primary renal proximal tubule epithelial cells (RPTECs) and characterized BKPyV entry and release. After 8 days on permeable inserts, RPTECs demonstrated apico-basal polarity. BKPyV entry was most efficient via the apical membrane, that in vivo faces the tubular lumen, and depended on sialic acids. Progeny release started between 48 and 58 hours post-infection (hpi), and was exclusively detected in the apical compartment. From 72 hpi, cell lysis and detachment gradually increased but cells were mainly shed by extrusion and the barrier function was therefore maintained. The decoy-like cells were BKPyV infected and could transmit BKPyV to uninfected cells. By 120 hpi, the epithelial barrier was disrupted by severe cytopathic effects, and BKPyV entered the basolateral compartment mimicking the interstitial space. Addition of BKPyV-specific neutralizing antibodies to this compartment inhibited new infections. Taken together, we propose that during in vivo low-level BKPyV replication, BKPyV disseminates inside the tubular system, thereby causing minimal damage and delaying immune detection. However, in kidney transplant recipients lacking a well-functioning immune system, replication in the allograft will progress and eventually cause denudation of the basement membrane, leading to an increased number of decoy cells, high-level BKPyV-DNAuria and DNAemia, the latter a marker of allograft damage.
Identifiants
pubmed: 37639485
doi: 10.1371/journal.ppat.1011622
pii: PPATHOGENS-D-23-01211
pmc: PMC10491296
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1011622Informations de copyright
Copyright: © 2023 Lorentzen et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Proc Natl Acad Sci U S A. 2011 Nov 8;108(45):18406-11
pubmed: 22042859
Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9379-84
pubmed: 18591669
J Immunol Methods. 1994 Aug 1;173(2):149-56
pubmed: 8046249
Am J Transplant. 2008 Nov;8(11):2368-77
pubmed: 18925904
Lancet Infect Dis. 2003 Oct;3(10):611-23
pubmed: 14522260
Adv Exp Med Biol. 2006;577:201-12
pubmed: 16626038
J Virol. 1989 May;63(5):2278-88
pubmed: 2539518
Am J Transplant. 2016 Feb;16(2):398-406
pubmed: 26731714
Virus Res. 2003 Jun;93(2):181-7
pubmed: 12782366
J Am Soc Nephrol. 1999 May;10(5):1080-9
pubmed: 10232695
Curr Opin Infect Dis. 2019 Dec;32(6):575-583
pubmed: 31567736
Nat Rev Mol Cell Biol. 2002 Dec;3(12):944-55
pubmed: 12461560
Open Biol. 2015 Aug;5(8):
pubmed: 26246492
Virology. 2004 Jun 1;323(2):182-8
pubmed: 15193914
Nat Biotechnol. 2019 Mar;37(3):303-313
pubmed: 30833775
J Antimicrob Chemother. 2018 Jan 01;73(1):12-21
pubmed: 29190347
PLoS One. 2018 Oct 23;13(10):e0206273
pubmed: 30352098
J Histochem Cytochem. 2001 Apr;49(4):501-10
pubmed: 11259453
J Cell Biol. 2022 Jun 6;221(6):
pubmed: 35420640
J Cell Physiol. 1990 Nov;145(2):222-37
pubmed: 1978836
Annu Rev Virol. 2016 Sep 29;3(1):517-532
pubmed: 27501263
J Gen Virol. 2017 Jun;98(6):1159-1160
pubmed: 28640744
Nephrol Dial Transplant. 2008 Dec;23(12):3752-61
pubmed: 18784088
Mol Cell Biol. 1988 Aug;8(8):3391-6
pubmed: 2850491
Nephrol Dial Transplant. 2001 Jul;16(7):1496-8
pubmed: 11427650
Antimicrob Agents Chemother. 2010 Nov;54(11):4714-22
pubmed: 20713664
Semin Cell Dev Biol. 2017 Jul;67:132-140
pubmed: 27212253
Exp Cell Res. 1994 Jun;212(2):291-6
pubmed: 7910563
J Virol. 2001 Dec;75(23):11834-50
pubmed: 11689665
Am J Physiol Renal Physiol. 2015 Jun 1;308(11):F1200-6
pubmed: 25656364
Kidney Int. 2000 Jun;57(6):2386-402
pubmed: 10844608
J Virol. 2006 Feb;80(3):1361-6
pubmed: 16415013
Nephrol Dial Transplant. 2014 Nov;29(11):2004-11
pubmed: 24589723
J Am Soc Nephrol. 2002 Aug;13(8):2145-51
pubmed: 12138148
Virol J. 2020 Jan 10;17(1):5
pubmed: 31924245
Virology. 1992 Sep;190(1):393-402
pubmed: 1326810
Am J Transplant. 2003 Nov;3(11):1383-92
pubmed: 14525599
N Engl J Med. 2002 Aug 15;347(7):488-96
pubmed: 12181403
Am J Physiol Renal Physiol. 2002 Feb;282(2):F358-65
pubmed: 11788451
Transplantation. 1999 Mar 27;67(6):918-22
pubmed: 10199744
Virology. 2015 May;479-480:444-9
pubmed: 25890822
J Virol. 2020 Feb 28;94(6):
pubmed: 31896595
J Clin Microbiol. 2011 Apr;49(4):1382-8
pubmed: 21325560
Antiviral Res. 2011 Oct;92(1):115-23
pubmed: 21798289
Am J Physiol Renal Physiol. 2011 Mar;300(3):F589-601
pubmed: 21228104
J Virol. 2005 Nov;79(22):14442-5
pubmed: 16254379
Am J Transplant. 2008 Jul;8(7):1413-22
pubmed: 18510636
Am J Physiol Renal Physiol. 2009 Jun;296(6):F1439-51
pubmed: 19297449
J Histochem Cytochem. 1983 Jan;31(1A Suppl):139-44
pubmed: 6186720
J Cell Biol. 1978 Jun;77(3):853-80
pubmed: 567227
Clin Transplant. 2019 Sep;33(9):e13528
pubmed: 30859620
Elife. 2023 Mar 24;12:
pubmed: 36961501
iScience. 2020 Jul 24;23(7):101257
pubmed: 32599557
Front Endocrinol (Lausanne). 2022 Apr 08;13:834187
pubmed: 35464062
Sci Rep. 2022 Aug 1;12(1):13182
pubmed: 35915212
Cell Rep. 2023 Feb 14;42(2):112114
pubmed: 36790933
Nat Microbiol. 2023 Apr;8(4):629-639
pubmed: 36914754
Exp Cell Res. 2014 Apr 15;323(1):87-99
pubmed: 24560744
J Virol. 1998 Jul;72(7):6233-6
pubmed: 9621096
Acta Pharm Sin B. 2016 Sep;6(5):363-373
pubmed: 27709005
Cell Microbiol. 2003 Mar;5(3):155-64
pubmed: 12614459
Cell Death Differ. 2018 Mar;25(3):486-541
pubmed: 29362479
Cell Host Microbe. 2011 Feb 17;9(2):93-102
pubmed: 21320692
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):
pubmed: 33836570
J Clin Invest. 2014 May;124(5):2219-33
pubmed: 24713657
Cell Microbiol. 2012 May;14(5):656-68
pubmed: 22233276
PLoS Pathog. 2013;9(10):e1003688
pubmed: 24130487
Lancet. 1971 Jun 19;1(7712):1253-7
pubmed: 4104714
FEBS J. 2008 Dec;275(23):6043-56
pubmed: 19021775
Oncogene. 2021 Jan;40(1):46-54
pubmed: 33051598
J Virol. 2016 Oct 28;90(22):10398-10413
pubmed: 27630227
Am J Transplant. 2005 Mar;5(3):582-94
pubmed: 15707414